Childhood Vaccine Schedule: Where is the Science?

Childhood Vaccine Schedule: Where is the Science?
The Childhood Vaccine Schedule Not Adequately Tested
However, a report released by the Institute of Medicine (IOM) in 2013, The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence and Future Studies, contradicts the firm position that the CDC, AAP and AAFP hold with respect to the safety of the schedule
First, the concept of the immunization “schedule” is not well developed in the scientific literature. Most vaccine research focuses on the health outcomes associated with single immunizations or combinations of vaccines administered at a single visit. Even though each new vaccine is evaluated in the context of the overall immunization schedule that existed at the time of review, individual elements of the schedule are not evaluated once it is adjusted to accommodate a new vaccine. Key elements of the immunization schedule—for example, the number, frequency, timing, order, and age at the time of administration of vaccines—have not been systematically examined in research studies
Is the Child Vaccine Schedule Associated with Chronic Disease and Brain Disorders?
The IOM Committee also discovered that there is very limited information about subpopulations of vulnerable children, who may be biologically at greater risk for suffering vaccine injury and death.
The committee found that evidence assessing outcomes in subpopulations of children, who may be potentially susceptible to adverse reactions to vaccines (such as children with a family history of autoimmune disease or allergies or children born prematurely), is limited and is characterized by uncertainty about the definition of populations of interest and definition of exposures or outcomes.
Additionally, the IOM report acknowledged that vaccine safety is not a high enough priority for federal health officials making vaccine use recommendations and goes on to say:
The childhood immunization schedule may become more complex over time as scientific advances are made and new vaccines are developed. Feasible research approaches to study potential adverse health outcomes will emerge only with a sustained and substantial federal commitment to research on vaccine safety

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s